TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ValiRx plc ( (GB:VAL) ) just unveiled an announcement.
ValiRx PLC has successfully raised approximately £902,000 through its WRAP Retail Offer and other fundraising activities, issuing new ordinary shares at a price of 0.25 pence per share. This capital injection is expected to support the company’s ongoing operations and strategic initiatives, potentially strengthening its position in the life sciences industry and providing value to its stakeholders.
The most recent analyst rating on (GB:VAL) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on ValiRx plc stock, see the GB:VAL Stock Forecast page.
Spark’s Take on GB:VAL Stock
According to Spark, TipRanks’ AI Analyst, GB:VAL is a Underperform.
ValiRx plc’s overall stock score is primarily impacted by its challenging financial performance, marked by significant losses and reliance on external financing. The technical analysis indicates bearish trends, with the stock being oversold. Valuation metrics are unfavorable due to negative earnings and lack of dividends. These factors collectively suggest a high-risk investment profile.
To see Spark’s full report on GB:VAL stock, click here.
More about ValiRx plc
ValiRx PLC is a life sciences company that specializes in early-stage cancer therapeutics and women’s health. The company is focused on developing innovative treatments in these areas, aiming to make significant advancements in the healthcare sector.
Average Trading Volume: 2,804,398
Technical Sentiment Signal: Sell
Current Market Cap: £935.9K
Learn more about VAL stock on TipRanks’ Stock Analysis page.